NeurAxis, Inc.
AMEX: NRXS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange American
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Brian Carrico
- Employees
- 21
- Headquarters
- Carmel, United States
- IPO year
- 2023
- Market cap
- $88.5M
- Website
- https://neuraxis.com
Loading NRXS…
Loading profile data…Frequently asked questions about NRXS
What does NeurAxis, Inc. (NRXS) do?
NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare...
Where does NRXS trade?
NeurAxis, Inc. (NRXS) trades on the New York Stock Exchange American.
What sector is NRXS in?
NeurAxis, Inc. (NRXS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of NeurAxis, Inc.?
Brian Carrico is the chief executive officer of NeurAxis, Inc. (NRXS).
Where is NeurAxis, Inc. headquartered?
NeurAxis, Inc. is headquartered in United States.
Does NRXS pay a dividend?
NeurAxis, Inc. (NRXS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NRXS go public?
NeurAxis, Inc. (NRXS) completed its initial public offering in 2023.